Display options
Cite
Ashrafizadeh M, Zarrabi A, Saberifar S, et al. Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines. 2020;8(5)doi: 10.3390/biomedicines8050110.
Ashrafizadeh, M., Zarrabi, A., Saberifar, S., Hashemi, F., Hushmandi, K., Hashemi, F., Moghadam, E. R., Mohammadinejad, R., Najafi, M., & Garg, M. (2020). Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines, 8(5), . https://doi.org/10.3390/biomedicines8050110
Ashrafizadeh, Milad, et al. "Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways." Biomedicines vol. 8,5 (2020). doi: https://doi.org/10.3390/biomedicines8050110
Ashrafizadeh M, Zarrabi A, Saberifar S, Hashemi F, Hushmandi K, Hashemi F, Moghadam ER, Mohammadinejad R, Najafi M, Garg M. Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines. 2020 May 05;8(5). doi: 10.3390/biomedicines8050110. PMID: 32380783; PMCID: PMC7277899.
Copy Download .nbib Format: NLM
Share it on

Biomedicines. 2020 May 05;8(5). doi: 10.3390/biomedicines8050110.

Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways.

Biomedicines

Milad Ashrafizadeh, Ali Zarrabi, Sedigheh Saberifar, Farid Hashemi, Kiavash Hushmandi, Fardin Hashemi, Ebrahim Rahmani Moghadam, Reza Mohammadinejad, Masoud Najafi, Manoj Garg

Affiliations

  1. Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz, Tabriz 5166616471, Iran.
  2. Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956 Istanbul, Turkey.
  3. Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz 6135783151, Iran.
  4. DVM. Graduated, Young Researcher and Elite Club, Kazerun Branch, Islamic Azad University, Kazeroon 7319846451, Iran.
  5. Department of Food Hygiene and Quality Control, Division of epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran 1417414418, Iran.
  6. Student Research Committee, Department of physiotherapy, faculty of rehabilitation, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715749, Iran.
  7. Student Research Committee, Department of Anatomical Sciences, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran.
  8. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman 7619813159, Iran.
  9. Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah 6715847141, Iran.
  10. Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida-201313, India.

PMID: 32380783 PMCID: PMC7277899 DOI: 10.3390/biomedicines8050110

Abstract

Cancer therapy is a growing field, and annually, a high number of research is performed to develop novel antitumor drugs. Attempts to find new antitumor drugs continue, since cancer cells are able to acquire resistance to conventional drugs. Natural chemicals can be considered as promising candidates in the field of cancer therapy due to their multiple-targeting capability. The nobiletin (NOB) is a ubiquitous flavone isolated from Citrus fruits. The NOB has a variety of pharmacological activities, such as antidiabetes, antioxidant, anti-inflammatory, hepatoprotective, and neuroprotective. Among them, the antitumor activity of NOB has been under attention over recent years. In this review, we comprehensively describe the efficacy of NOB in cancer therapy. NOB induces apoptosis and cell cycle arrest in cancer cells. It can suppress migration and invasion of cancer cells via the inhibition of epithelial-to-mesenchymal transition (EMT) and EMT-related factors such as TGF-β, ZEB, Slug, and Snail. Besides, NOB inhibits oncogene factors such as STAT3, NF-κB, Akt, PI3K, Wnt, and so on. Noteworthy, onco-suppressor factors such as microRNA-7 and -200b undergo upregulation by NOB in cancer therapy. These onco-suppressor and oncogene pathways and mechanisms are discussed in this review.

Keywords: cancer therapy; citrus; flavonoid; herbal compound; nobiletin; signaling pathway

Conflict of interest statement

The authors declare no conflicts of interest.

References

  1. Immunopharmacol Immunotoxicol. 2020 Apr;42(2):93-100 - PubMed
  2. Int J Mol Sci. 2020 Feb 06;21(3): - PubMed
  3. PLoS One. 2016 Apr 20;11(4):e0153155 - PubMed
  4. Nutrients. 2019 Nov 04;11(11): - PubMed
  5. Eur J Pharmacol. 2020 May 15;875:172939 - PubMed
  6. Biomed Chromatogr. 2006 Nov;20(11):1206-15 - PubMed
  7. Z Naturforsch C J Biosci. 2020 Mar 26;75(3-4):113-120 - PubMed
  8. J Cell Physiol. 2012 May;227(5):2184-95 - PubMed
  9. Mol Carcinog. 2018 May;57(5):664-677 - PubMed
  10. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1155-64 - PubMed
  11. Front Pharmacol. 2016 Oct 25;7:395 - PubMed
  12. Front Pharmacol. 2019 May 31;10:570 - PubMed
  13. Evid Based Complement Alternat Med. 2013;2013:698190 - PubMed
  14. World J Gastroenterol. 2015 Nov 21;21(43):12261-73 - PubMed
  15. EBioMedicine. 2019 Jun;44:439-451 - PubMed
  16. J Agric Food Chem. 2018 Jan 10;66(1):91-98 - PubMed
  17. Oncol Lett. 2020 Jan;19(1):406-414 - PubMed
  18. Food Sci Nutr. 2019 Feb 10;7(3):1104-1112 - PubMed
  19. Mol Med Rep. 2013 Apr;7(4):1173-9 - PubMed
  20. J Leukoc Biol. 2017 Mar;101(3):775-783 - PubMed
  21. Semin Cell Dev Biol. 2017 Mar;63:135-143 - PubMed
  22. Food Funct. 2019 Nov 1;10(11):7444-7452 - PubMed
  23. Cells. 2019 Sep 30;8(10): - PubMed
  24. Cell Death Differ. 2004 Apr;11(4):372-80 - PubMed
  25. Cell Mol Life Sci. 2010 Nov;67(21):3649-62 - PubMed
  26. Eur J Cell Biol. 2020 Apr;99(2-3):151073 - PubMed
  27. Mol Cancer Ther. 2020 Mar;19(3):765-776 - PubMed
  28. J Transl Med. 2019 Oct 26;17(1):352 - PubMed
  29. Nat Commun. 2019 Aug 28;10(1):3923 - PubMed
  30. Asian Pac J Cancer Prev. 2020 Mar 01;21(3):611-620 - PubMed
  31. Biomed Pharmacother. 2018 Jul;103:29-37 - PubMed
  32. Oncotarget. 2016 Jun 7;7(23):35208-23 - PubMed
  33. Science. 1992 Dec 4;258(5088):1650-4 - PubMed
  34. J Pharmacol Sci. 2018 Jun;137(2):116-121 - PubMed
  35. Cell Mol Biol Lett. 2020 Feb 24;25:8 - PubMed
  36. Cancers (Basel). 2018 Dec 27;11(1): - PubMed
  37. Pharmacol Res. 2020 Mar;153:104635 - PubMed
  38. Clin Sci (Lond). 2020 Mar 27;134(6):571-592 - PubMed
  39. Mol Cell Biochem. 2011 Jan;347(1-2):103-15 - PubMed
  40. J Biol Chem. 2012 Nov 2;287(45):38028-40 - PubMed
  41. Biomolecules. 2019 Dec 23;10(1): - PubMed
  42. Data Brief. 2018 Nov 01;21:2395-2397 - PubMed
  43. Am J Cancer Res. 2016 Sep 01;6(9):1842-1863 - PubMed
  44. Front Oncol. 2018 Jun 08;8:214 - PubMed
  45. Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3805-3817 - PubMed
  46. J Agric Food Chem. 2019 May 8;67(18):5122-5134 - PubMed
  47. Arch Toxicol. 2014 Oct;88(10):1787-802 - PubMed
  48. Drug Des Devel Ther. 2019 Jul 17;13:2371-2379 - PubMed
  49. J Lipid Res. 2020 Mar;61(3):387-402 - PubMed
  50. Onco Targets Ther. 2020 Jan 16;13:513-523 - PubMed
  51. Int J Mol Sci. 2017 Apr 30;18(5): - PubMed
  52. Neoplasma. 2020 May;67(3):595-603 - PubMed
  53. Nutrients. 2018 Jun 15;10(6): - PubMed
  54. Biochem Cell Biol. 2017 Aug;95(4):468-473 - PubMed
  55. Annu Rev Immunol. 2003;21:335-76 - PubMed
  56. J Cell Commun Signal. 2020 Jun;14(2):233-244 - PubMed
  57. Ann Surg Oncol. 2008 Mar;15(3):915-22 - PubMed
  58. Science. 2004 Sep 3;305(5689):1411-3 - PubMed
  59. Blood. 1998 Mar 1;91(5):1700-5 - PubMed
  60. Int J Mol Sci. 2020 Mar 09;21(5): - PubMed
  61. J Agric Food Chem. 1999 Sep;47(9):3565-71 - PubMed
  62. Nat Rev Immunol. 2007 May;7(5):353-64 - PubMed
  63. Phytomedicine. 2013 Jun 15;20(8-9):743-52 - PubMed
  64. Nutr Cancer. 2019;71(8):1299-1312 - PubMed
  65. J Steroid Biochem Mol Biol. 2005 Apr;94(5):461-7 - PubMed
  66. Int J Cancer. 1998 Jun 10;76(6):836-41 - PubMed
  67. Aging (Albany NY). 2019 Dec 31;12(1):80-105 - PubMed
  68. Molecules. 2019 Aug 08;24(16): - PubMed
  69. Exp Mol Med. 2019 Apr 26;51(4):1-16 - PubMed
  70. Chem Commun (Camb). 2011 Mar 14;47(10):2868-70 - PubMed
  71. Carcinogenesis. 2008 Nov;29(11):2162-8 - PubMed
  72. ChemMedChem. 2020 Jun 4;15(11):970-981 - PubMed
  73. J Clin Med. 2019 Nov 20;8(12): - PubMed
  74. J Orthop Surg Res. 2020 Mar 4;15(1):87 - PubMed
  75. Cancer Cell Int. 2015 Jul 15;15:71 - PubMed
  76. J Pharm Sci. 2020 Mar 13;: - PubMed
  77. Neurosci Bull. 2020 Mar 20;: - PubMed
  78. Biochim Biophys Acta. 2012 Mar;1820(3):403-10 - PubMed
  79. J Biochem Mol Toxicol. 2020 Feb;34(2):e22427 - PubMed
  80. Biochem Biophys Res Commun. 2013 Sep 13;439(1):54-9 - PubMed
  81. Acta Crystallogr C Struct Chem. 2016 Feb;72(Pt 2):124-7 - PubMed
  82. J Cell Biochem. 2019 Jun;120(6):9810-9819 - PubMed
  83. Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:95-101 - PubMed
  84. J Agric Food Chem. 2018 Dec 26;66(51):13423-13434 - PubMed
  85. Annu Rev Pharmacol Toxicol. 2014;54:95-117 - PubMed
  86. Front Oncol. 2020 Feb 04;10:94 - PubMed
  87. Nat Rev Immunol. 2014 May;14(5):329-42 - PubMed
  88. Biomed Pharmacother. 2020 May;125:110001 - PubMed
  89. Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):173-180 - PubMed
  90. Pharmacol Res. 2020 Mar;153:104660 - PubMed
  91. Cells. 2020 Apr 03;9(4): - PubMed
  92. Int Immunopharmacol. 2019 Aug;73:98-107 - PubMed
  93. Cancer Lett. 2014 Apr 1;345(1):140-8 - PubMed
  94. Nat Cell Biol. 2000 May;2(5):249-56 - PubMed
  95. Pharmazie. 2015 Apr;70(4):256-62 - PubMed
  96. Phytother Res. 2014 Apr;28(4):560-7 - PubMed
  97. Oncogene. 2004 Jan 22;23(3):753-62 - PubMed
  98. Mol Med Rep. 2014 Nov;10(5):2255-62 - PubMed
  99. Oncoimmunology. 2019 Aug 20;8(11):e1655364 - PubMed
  100. Mol Nutr Food Res. 2013 Nov;57(11):1999-2007 - PubMed
  101. Antioxid Redox Signal. 2016 Apr 10;24(11):575-89 - PubMed
  102. Molecules. 2016 Sep 16;21(9): - PubMed
  103. Phytomedicine. 2020 Apr;69:153184 - PubMed
  104. Oncogene. 2002 Mar 27;21(13):2000-8 - PubMed
  105. Oncogene. 2003 Oct 20;22(47):7496-511 - PubMed
  106. Aging (Albany NY). 2020 Feb 3;12(3):2393-2407 - PubMed
  107. Int J Cancer. 2009 Mar 1;124(5):1028-36 - PubMed
  108. Mol Nutr Food Res. 2006 Mar;50(3):291-9 - PubMed
  109. Cancer. 2001 Feb 15;91(4):854-62 - PubMed
  110. Semin Cancer Biol. 2020 Feb 14;: - PubMed
  111. Inflammation. 2020 Feb;43(1):336-346 - PubMed
  112. Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1121-1130 - PubMed
  113. Pathol Int. 2002 Apr;52(4):255-64 - PubMed
  114. Int J Mol Sci. 2019 Sep 01;20(17): - PubMed
  115. Oxid Med Cell Longev. 2015;2015:230182 - PubMed
  116. Cell Death Dis. 2019 Feb 27;10(3):204 - PubMed
  117. Front Pharmacol. 2017 Mar 20;8:124 - PubMed
  118. Trends Cell Biol. 2020 Jul;30(7):537-555 - PubMed
  119. Onco Targets Ther. 2019 Dec 16;12:11097-11105 - PubMed
  120. J Hepatol. 2020 Jan;72(1):183-196 - PubMed
  121. Int J Mol Sci. 2020 Jan 04;21(1): - PubMed
  122. Cancers (Basel). 2019 Jun 21;11(6): - PubMed
  123. Semin Cancer Biol. 2020 Apr 20;: - PubMed
  124. Oncol Lett. 2019 Dec;18(6):5709-5716 - PubMed
  125. J Cell Biochem. 2018 Jul;119(7):5243-5252 - PubMed
  126. Int J Oncol. 2015;46(6):2629-38 - PubMed
  127. J Recept Signal Transduct Res. 2020 Feb;40(1):49-57 - PubMed
  128. Expert Opin Ther Targets. 2015 Mar;19(3):307-20 - PubMed
  129. Eur J Pharm Sci. 2013 Jul 16;49(4):453-60 - PubMed
  130. J Pharmacol Sci. 2019 May;140(1):48-53 - PubMed
  131. J Ethnopharmacol. 2020 Apr 24;252:112601 - PubMed
  132. Semin Cancer Biol. 2016 Oct;40-41:1-3 - PubMed
  133. Cell Death Dis. 2019 Nov 25;10(12):887 - PubMed
  134. Mol Cancer Ther. 2004 Jul;3(7):839-47 - PubMed
  135. Biochem Biophys Res Commun. 2013 Feb 15;431(3):530-4 - PubMed
  136. Blood. 2015 Nov 26;126(22):2491-501 - PubMed
  137. Cancer Sci. 2019 Sep;110(9):2760-2772 - PubMed
  138. Food Funct. 2018 Jan 24;9(1):87-95 - PubMed
  139. Biochem Biophys Res Commun. 2008 Feb 1;366(1):168-73 - PubMed
  140. Elife. 2014 Nov 17;3:e03896 - PubMed
  141. Atherosclerosis. 2020 Mar;297:32-39 - PubMed
  142. Chem Pharm Bull (Tokyo). 2003 Dec;51(12):1426-8 - PubMed
  143. Molecules. 2019 Apr 22;24(8): - PubMed
  144. Life Sci. 2001 Jul 13;69(8):901-13 - PubMed
  145. Mol Cancer Ther. 2016 Dec;15(12):2966-2976 - PubMed
  146. Evid Based Complement Alternat Med. 2018 Feb 7;2018:7420265 - PubMed
  147. Cell Death Dis. 2020 Mar 2;11(3):163 - PubMed
  148. Anticancer Res. 2014 Apr;34(4):1785-92 - PubMed
  149. Biosci Rep. 2020 Apr 30;40(4): - PubMed
  150. Sci Rep. 2020 Jan 29;10(1):1438 - PubMed
  151. Oncoimmunology. 2018 Feb 1;7(5):e1423170 - PubMed
  152. Ann Surg Oncol. 2020 Feb;27(2):610-619 - PubMed
  153. J Cell Biochem. 2019 Mar;120(3):3467-3473 - PubMed
  154. Mol Cancer Ther. 2008 Jun;7(6):1604-14 - PubMed
  155. Sci Rep. 2019 Aug 12;9(1):11701 - PubMed
  156. Biochem Biophys Res Commun. 2019 Jan 1;508(1):97-101 - PubMed
  157. J Pharmacol Exp Ther. 2010 Jul;334(1):285-93 - PubMed
  158. J Cell Physiol. 2017 Feb;232(2):346-354 - PubMed
  159. Exp Mol Pathol. 2020 Apr;113:104367 - PubMed
  160. Oral Dis. 2020 May;26(4):745-755 - PubMed
  161. Cancer. 2019 Apr 15;125(8):1228-1246 - PubMed
  162. Biol Trace Elem Res. 2020 Jan 30;: - PubMed
  163. Biochem Biophys Res Commun. 2020 May 21;526(1):170-175 - PubMed
  164. Anticancer Drugs. 2020 Apr;31(4):377-384 - PubMed
  165. J Biol Chem. 1999 Oct 8;274(41):29568-71 - PubMed
  166. Cell Death Dis. 2019 Nov 6;10(11):843 - PubMed
  167. Mol Cancer Res. 2019 Nov;17(11):2306-2317 - PubMed
  168. Med Res Rev. 2008 Mar;28(2):185-200 - PubMed
  169. Front Biosci (Landmark Ed). 2019 Jan 1;24:303-312 - PubMed
  170. Food Chem Toxicol. 2014 May;67:193-200 - PubMed
  171. Nutr Cancer. 2013;65(2):286-95 - PubMed
  172. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3529-34 - PubMed
  173. Phytother Res. 2019 Jun;33(6):1717-1725 - PubMed
  174. Food Nutr Res. 2018 Nov 21;62: - PubMed
  175. Nutrients. 2020 Feb 14;12(2): - PubMed
  176. Oncotarget. 2015 Mar 20;6(8):6386-405 - PubMed
  177. Food Chem Toxicol. 2012 Sep;50(9):3320-8 - PubMed
  178. Cells. 2019 Sep 20;8(10): - PubMed
  179. J Agric Food Chem. 2020 Feb 5;68(5):1326-1336 - PubMed
  180. J Nutr Biochem. 2012 Oct;23(10):1230-7 - PubMed
  181. Cancer Lett. 2007 Jun 18;251(1):168-78 - PubMed
  182. Eur J Pharmacol. 2019 Jul 5;854:48-53 - PubMed
  183. Front Immunol. 2014 Jul 23;5:352 - PubMed
  184. BMC Anesthesiol. 2020 Feb 21;20(1):43 - PubMed
  185. Nutr Cancer. 2018 Feb-Mar;70(2):257-266 - PubMed
  186. Nutr Cancer. 2011;63(2):161-73 - PubMed
  187. J Cancer Res Oncobiol. 2018;1(2): - PubMed
  188. Front Pharmacol. 2019 Jul 09;10:690 - PubMed
  189. Pharm Biol. 2012 Oct;50(10):1210-8 - PubMed
  190. Food Funct. 2019 Apr 17;10(4):1880-1892 - PubMed
  191. Oncol Rep. 2017 May;37(5):2847-2856 - PubMed
  192. Int J Nanomedicine. 2019 Sep 26;14:7839-7849 - PubMed
  193. J Nat Prod. 2012 Nov 26;75(11):1896-902 - PubMed
  194. Toxicol Lett. 2014 Oct 15;230(2):304-13 - PubMed
  195. Mol Nutr Food Res. 2015 Dec;59(12):2383-94 - PubMed
  196. Semin Cancer Biol. 2016 Oct;40-41:48-81 - PubMed
  197. Oncol Rep. 2016 May;35(5):2767-74 - PubMed
  198. Cell Mol Life Sci. 2019 May;76(10):1947-1966 - PubMed
  199. Cancers (Basel). 2019 Feb 22;11(2): - PubMed
  200. Mol Carcinog. 2014 Oct;53(10):793-806 - PubMed
  201. Semin Cancer Biol. 2019 Aug 14;: - PubMed
  202. BMC Plant Biol. 2016 Aug 22;16(1):180 - PubMed
  203. Mol Ther Nucleic Acids. 2020 Mar 6;19:974-985 - PubMed
  204. Acta Pharm Sin B. 2020 Feb;10(2):327-343 - PubMed
  205. Planta Med. 2014 Apr;80(6):452-7 - PubMed
  206. J Agric Food Chem. 2015 Jan 21;63(2):509-16 - PubMed
  207. Carcinogenesis. 2017 Apr 1;38(4):455-464 - PubMed
  208. Cancer Res. 2000 Sep 15;60(18):5059-66 - PubMed
  209. Xenobiotica. 2011 Nov;41(11):927-33 - PubMed
  210. Int J Oncol. 2020 Mar;56(3):750-760 - PubMed
  211. Molecules. 2016 Jul 14;21(7): - PubMed
  212. Food Funct. 2019 Apr 17;10(4):2161-2175 - PubMed
  213. Phytother Res. 2016 Feb;30(2):214-21 - PubMed
  214. Mol Nutr Food Res. 2014 Aug;58(8):1721-38 - PubMed
  215. Cell Biol Int. 2020 Jun;44(6):1382-1393 - PubMed
  216. Open Med (Wars). 2020 Mar 06;15:126-133 - PubMed
  217. J Cancer. 2020 Feb 10;11(9):2408-2420 - PubMed
  218. Cell Death Dis. 2020 Mar 23;11(3):202 - PubMed
  219. J Agric Food Chem. 2015 Aug 19;63(32):7180-9 - PubMed
  220. Cancer Lett. 2009 Jan 18;273(2):194-200 - PubMed
  221. J Biomed Sci. 2020 Mar 13;27(1):42 - PubMed
  222. CA Cancer J Clin. 2017 Jan;67(1):7-30 - PubMed
  223. Nutrients. 2018 Nov 26;10(12): - PubMed
  224. Biomed Pharmacother. 2020 Jun;126:110019 - PubMed
  225. Pharmacol Res. 2019 Dec;150:104504 - PubMed
  226. Eur J Med Chem. 2020 May 1;193:112194 - PubMed
  227. J Biol Chem. 2014 Dec 5;289(49):34296-307 - PubMed
  228. Biochem Pharmacol. 2012 Nov 15;84(10):1268-76 - PubMed
  229. Naunyn Schmiedebergs Arch Pharmacol. 2020 Feb 6;: - PubMed
  230. BJS Open. 2020 Apr;4(2):284-292 - PubMed
  231. PLoS One. 2012;7(10):e47299 - PubMed
  232. Cancer Prev Res (Phila). 2013 Aug;6(8):843-54 - PubMed
  233. J Cell Biochem. 2018 Sep 11;: - PubMed
  234. Am J Transl Res. 2019 Sep 15;11(9):5967-5977 - PubMed
  235. Food Res Int. 2020 Jan;127:108691 - PubMed
  236. BMC Pharmacol Toxicol. 2014 Oct 24;15:59 - PubMed
  237. Nutr Cancer. 2020;72(2):352-363 - PubMed
  238. Drug Resist Updat. 2020 Mar;49:100681 - PubMed
  239. Oncotarget. 2014 Feb 15;5(3):634-48 - PubMed
  240. Sci Rep. 2015 Dec 22;5:18789 - PubMed
  241. Molecules. 2020 Jan 28;25(3): - PubMed
  242. Cancer Med. 2019 Dec;8(18):7822-7832 - PubMed
  243. Front Immunol. 2012 May 08;3:107 - PubMed
  244. Science. 2003 Jan 10;299(5604):214-5 - PubMed
  245. JCI Insight. 2020 Apr 9;5(7): - PubMed
  246. Expert Opin Investig Drugs. 2017 Aug;26(8):883-887 - PubMed
  247. Evid Based Complement Alternat Med. 2016;2016:2918796 - PubMed
  248. Biochem Biophys Res Commun. 2018 Jan 1;495(1):1418-1425 - PubMed
  249. Drug Des Devel Ther. 2020 Feb 05;14:527-538 - PubMed
  250. Sci Rep. 2019 Dec 27;9(1):20191 - PubMed
  251. Pharm Res. 2020 Mar 12;37(3):67 - PubMed
  252. Food Chem Toxicol. 2018 Mar;113:228-235 - PubMed
  253. Molecules. 2019 Jan 30;24(3): - PubMed
  254. Clin Exp Immunol. 2016 May;184(2):147-58 - PubMed
  255. Redox Biol. 2019 Jul;25:101073 - PubMed
  256. Cancer Cell Int. 2020 Jan 3;20:4 - PubMed
  257. Stem Cell Res Ther. 2020 Mar 20;11(1):130 - PubMed

Publication Types

Grant support